Anthelmintic Drugs Market Potential Effect on Upcoming Future Growth by Top Vendors: Novartis, Cipla, Sun Pharma, Johnson & Johnson, Mankind
Helminths, also known as parasitic worms, are multicellular organisms and can be seen with the naked eye. These parasites are transmitted through soil, bite of vector, and penetration by larva. Soil-transmitted infections are most common and affect nearly 2 billion people in the world, including children. According to WHO estimates, 870 million children live areas with high prevalence of helminths infections. South Asia, Africa, and South America are the most affected regions of the world. The warm and moist climate of tropical and subtropical countries provides an ideal environment for the survival of the parasite’s eggs. In addition, prevalence of infections is also linked with quality of water, hygiene practices, and socioeconomic status of affected areas. Helminths harm the host by causing injury to organs such as the intestines and by secreting toxic substances. Helminths infections are most common in rural areas, especially in warm, humid equatorial regions or where sanitation facilities are inadequate. Helminths are broadly classified into the three major groups: cestodes (tapeworms), nematodes (round warm), and trematodes (flukes). Nematodes are called intestinal parasites e.g. Ascaris lumbricoides, Enterobius vermicularis, etc. and are transmitted through undercooked food.
Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling). They act through different mechanisms. For instance, some drugs such as Levamisole and Pyrantel act as agonists at the acetylcholine receptor. Piperazin cause flaccid paralysis by acting on GABA receptors. Avermectines increase the opening of glutamate-gated chloride channel. Chemotherapy is the drug of choice for helminthic infections. Nematodas are treated with Diethylcarbamazin citrate (DEC), Ivermectin, Mebendazole, Pyrantel, and Thiabendazol. Trematode infections are treated with Praziquantel, and cestodes infections are treated with Albendazol and Niclosamide. These drugs can be administered topically, intravenously, and orally. Common side effects of anthelmintic drugs include abdominal pain, diarrhea, vomiting, abdominal discomfort, etc.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/6693
Resistance is a significant problem with anthelmintic drugs. Causes of resistance include high treatment frequency, single drug regimen, and under dosing. Research is being conducted to overcome anthelmintic drug resistance by developing drugs that target metabolic pathways. For instance, nicotinic acetylcholine receptor inhibitor (S)-5-ethynyl-anabasine derivative and combinations of anthelmintics with a similar spectrum of activity and different mechanisms of action.
Key drivers of the anthelmintic drugs market include continuously rising prevalence of helminthic infections, increase in novel drug development, government initiatives for creating awareness about the various diseases, affordability of drugs, and high adoption of drugs in developing countries. However, lack of awareness among the rural population, stiff competition, and severity involved in taking the wrong medication due to misdiagnosis or incorrect self-diagnosis could restrain the anthelmintic drugs market.
The global anthelmintic drugs market can be segmented based on application, route of administration, distribution channel, and geography. Based on application, the anthelmintic drugs market can be classified into drugs for human being and drugs for animals. In terms of route of administration, the anthelmintic drugs market can be categorized into oral, topical, and intravenous. Based on distribution channel, the market can be split into hospital pharmacies, retail pharmacies, online pharmacies, mail order pharmacies, and others. In terms of geography, the anthelmintic drugs market can be segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, and France), Asia Pacific (Japan, Australia, India, China, etc.), Latin America (Mexico and Brazil), and Middle East & Africa (GCC Countries, South Africa, etc.). North America is a significant region of the anthelmintic drug market, followed by Europe, where the prevalence of drug resistance is likely to be low. The anthelmintic drugs market in Asia Pacific is expanding due to increase in incidence of helminths infections, rise in awareness about helminths diseases and drug availability and expansion in the health care industry in the region.
Major players in the global anthelmintic drugs market include Novartis AG, Pfizer, Inc., Bayer AG, Cipla, Inc., Sun Pharmaceutical Industries Ltd., Mankind Pharma, Johnson & Johnson Services, Inc., Impax laboratories Inc., and Merck & Co., Inc.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
Request For TOC Report @ https://www.marketresearchreports.biz/sample/toc/6693
The report provides the following information:
-Tailwinds and headwinds molding the market’s trajectory
-Market segments based on products, technology, and applications
-Prospects of each segment
-Overall current and possible future size of the market
-Growth pace of the market
-Competitive landscape and key players’ strategies
The main aim of the report is to:
-Enable key stakeholder’s in the market bet right on it
-Understand the opportunities and pitfalls awaiting them
-Assess the overall growth scope in the near term
-Strategize effectively with respect to production and distribution
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anthelmintic Drugs Market Potential Effect on Upcoming Future Growth by Top Vendors: Novartis, Cipla, Sun Pharma, Johnson & Johnson, Mankind here
News-ID: 1759306 • Views: …
More Releases for Helminths
Albendazole Anthelmintic Drug Market Growth, Trends, Industry Analysis and Forec …
The global albendazole anthelmintic drug market is anticipated to grow at a CAGR of 6.8% during the forecast period (2022-2028). As the number of cases of neurocysticercosis climbs in the next years, so will the demand for albendazole treatments (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). (Get 15% Discount on Buying this Report) A full report of Global
Anthelmintic Drugs Market To Reach Valuation Of ~US$ 4 Bn By 2027
Anthelmintic Drugs Market: Introduction According to the report, the global anthelmintic drugs market was valued at ~US$ 2 Bn in 2019 and is projected to expand at a moderate CAGR during the forecast period. Anthelmintic drugs are the group of the antiparasite drugs recommended for the treatment of the helminths in the body. Anthelmintic drugs are used to remove the parasitic forms, such as roundworm, flatworm, whipworm, and pinworm from animals
Global Albendazole (Cas 54965-21-8) Market Is Anticipated To Grow More Actively …
Albendazole is a wide-range of antihelminthics. The primary approach of action for albendazole is by its prohibitory significance on tubulin polymerization, which leads to the damage of cytoplasmic microtubules. This drug is a medication taken for the treatment of a several number of parasitic worm infestations. It is very beneficial in circumstances such as hydatid disease, giardiasis, filariasis, trichuriasis, neurocysticercosis, pinworm disease, and ascariasis, amongst others. The albendazole drug is
Antihelminthics Market Technology, Recent Trends, Future Growth Analysis Forecas …
Infinity Business Insights provides a comprehensive analysis of the Antihelminthics market and covers market growth, driving factors, restraints, opportunities and growth trajectory. Antihelmintics, also known as antihelminthics, are antiparasitic medications that are used to evacuate parasitic worms (helminths) and other serious illnesses from the body by startling or destroying them without harming the host. Request Sample Copy of Antihelminthics Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=603643 Top Key Players Included in Antihelminthics Market Report: Abbott, Novartis,
Global Nitazoxanide Drug Market Report Forecast to 2027
Nitazoxanide (NTZ) is a broad-spectrum anti-infective drug that markedly modulates the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, in addition to viruses. Get sample copy of this report @ https://www.infinitybusinessinsights.com/request_sample.php?id=624389 The Key players operating in the Nitazoxanide Drug market are: Romark Laboratories, Chugai Pharmaceutical, Lupin The organizations have embraced a few
Global Shigella Diarrhoea Prophylaxis Market is poised to achieve continuing gro …
Global shigella diarrhoea prophylaxis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The Shigella Diarrhoea Prophylaxis report encompasses thorough analysis of market with respect to several